← Back to Patent Explorer
EP0424871A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Leukocytes and hemiglobin in blood

Assignee: Sysmex Corp
•
Filing: 1990-10-23
•
Granted: —
•
Expires: 2010-10-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A reagent for measuring the hemoglobin concentration and counting the number of leukocytes in a blood sample, which contains at least one of a quaternary ammonium salt or a pyridinium salt, having a concentration capable of hemolyzing erythrocytes in the blood and denaturing hemoglo­bin and at least one of cationic, nonionic or amphoteric surfactants or an oxidant capable of oxidizing heme in hemoglobin, said reagent being capable of dividing leuko­cytes into two or three fractions, for example, a fraction of lymphocytes, a fraction of monocytes, eosinophils and basophils, and a fraction of neutrophils.

Inventors

  • 👤 Syouzou Toda
  • 👤 Takashi Sakata
  • 👤 Yukio Hamaguchi

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-08 08:44
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/5005; G01N33/5094; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/107497; Y10T436/108331

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 367 words
A reagent for enabling measuring a hemoglobin concen­tration to be measured and counting the number of leukocytes present in a blood sample to be counted, which is free of cyanides and satisfies the following conditions: i) it contains at least one of a quaternary ammonium salt (formula a) or a pyridinium salt (formula b), having a concentration capable of hemolyzing erythrocytes in the blood and denaturing hemoglobin: where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂, R₃ and R₄: C₁ to C₈ alkyl, alkenyl or alkinyl group, and X⁻: anionic group; where n: an integer of from 7 to 19, and X⁻: an anionic group; ii) it also contains at least one compound selected from the group consisting of cationic, nonionic or amphoteric surfactants as shown by the formulas c to e and an oxidant capable of oxidizing heme in hemoglobin as shown by the formula f: where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂ and R₃: C₁ to C₈ alkyl, alkenyl or alkinyl group, and X⁻: anionic group; formula d R₁ - R₂ - (CH₂CH₂O) n - H where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂: O, or COO, and n: an integer of from 10 to 50; where R₁: C₈ to C₂₀ alkyl group, and R₂ and R₃: C₁ to C₈ alkyl, alkenyl or alkinyl group; f.....nitrite ion, quinone compound, alloxan, methylene blue, aniline, acetanilide, nitrobenzene, acetophene­tidine, nitrotoluene, sulfonamide, phenylhydrazine, ascorbic acid or aminophenol; iii) it is a solution with a pH ranging from 3.0 to 9.0; iv) the total concentration of the quaternary ammonium salt is in the range of from 0.1 to 15.0 g/ℓ; v) the total concentration of the pyridinium salt is in the range of from 0.1 to 15. 0 g/ℓ; vi) the total concentration of the oxidant is in the range of from 0.5 to 10.0 g/ℓ; vii) the total concentration of the nonionic surfactant is in the range of from 0.1 to 15.0 g/ℓ; viii) the total concentration of the amphoteric surfactant is in the range of from 0.1 to 15.0 g/ℓ; and ix) the total concentration of the cationic surfactant is in the range of from 0.1 to 15.0 g/ℓ.
Claim 2
Dependent Claim 367 words
A reagent for enabling measuring a hemoglobin concen­tration to be measured and counting the number of leukocytes present in a blood sample to be counted, which is free of cyanides and satisfies the following conditions: i) it contains at least one of a quaternary ammonium salt (formula a) or a pyridinium salt (formula b), having a concentration capable of hemolyzing erythrocytes in the blood and denaturing hemoglobin: where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂, R₃ and R₄: C₁ to C₈ alkyl, alkenyl or alkinyl group, and X⁻: anionic group; where n: an integer of from 7 to 19, and X⁻: an anionic group; ii) it also contains at least one compound selected from the group consisting of cationic, nonionic or amphoteric surfactants as shown by the formulas c to e and an oxidant capable of oxidizing heme in hemoglobin as shown by the formula f: where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂ and R₃: C₁ to C₈ alkyl, alkenyl or alkinyl group, and X⁻: anionic group; formula d R₁ - R₂ - (CH₂CH₂O) n - H where R₁: C₈ to C₂₀ alkyl, alkenyl or alkinyl group, R₂: O, or COO, and n: an integer of from 10 to 50; where R₁: C₈ to C₂₀ alkyl group, and R₂ and R₃: C₁ to C₈ alkyl, alkenyl or alkinyl group; f.....nitrite ion, quinone compound, alloxan, methylene blue, aniline, acetanilide, nitrobenzene, acetophene­tidine, nitrotoluene, sulfonamide, phenylhydrazine, ascorbic acid or aminophenol; iii) it is a solution with a pH ranging from 3.0 to 9.0; iv) the total concentration of the quaternary ammonium salt is in the range of from 0.1 to 15.0 g/ℓ; v) the total concentration of the pyridinium salt is in the range of from 0.1 to 15. 0 g/ℓ; vi) the total concentration of the oxidant is in the range of from 0.5 to 10.0 g/ℓ; vii) the total concentration of the nonionic surfactant is in the range of from 0.1 to 15.0 g/ℓ; viii) the total concentration of the amphoteric surfactant is in the range of from 0.1 to 15.0 g/ℓ; and ix) the total concentration of the cationic surfactant is in the range of from 0.1 to 15.0 g/ℓ.
Claim 3
Dependent Claim 54 words
The reagent according to Claim 1 containing at least two of said quaternary ammonium salts, with the total con­centration of said quaternary ammonium salt or salts ranging between 0.1 g/ℓ and 12.0 g/ℓ, and at least one of oxidants selected from f, said reagent being capable of dividing leukocytes into at least two fractions.
Claim 4
Dependent Claim 103 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total concentration of said quaternary ammonium salt or salts ranging between 0.1 g/ℓ and 12.0 g/ℓ, said reagent also containing at least one of said nonionic surfactants, with the total concentration of said nonionic surfactant or surfactants ranging between 0.1 g/ℓ and 12.0 g/ℓ, said reagent also containing at least one of oxidants selected from f, with the total concentration of said oxidant or oxidants ranging between 0.5 g/ℓ and 10.0 g/ℓ, and said reagent being capable of dividing the leukocytes into at least two fractions.
Claim 5
Dependent Claim 75 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total con­centration of said quaternary ammonium salt or salts ranging between 0.1 g/ℓ and 12.0 g/ℓ, said reagent also containing at least one of said amphoteric surfactants, with the total concentration of said amphoteric surfactant or surfactants ranging between 0.1 g/ℓ and 12.0 g/ℓ, and said reagent being capable of dividing the leukocytes into at least two fractions.
Claim 6
Dependent Claim 75 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total con­centration of said quaternary ammonium salt or salts ranging between 1.0 g/ℓ and 10.0 g/ℓ, said reagent also containing at least one of said nonionic surfactants, with the total concentration of said nonionic surfactant or surfactants ranging between 0.1 g/ℓ and 12.0 g/ℓ, and said reagent being capable of dividing the leukocytes into at least two fractions.
Claim 7
Dependent Claim 75 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total con­centration of said quaternary ammonium salt or salts ranging between 1.0 g/ℓ and 12.0 g/ℓ, said reagent also containing at least one of said cationic surfactants, with the total concentration of said cationic surfactant or surfactants ranging between 0.1 g/ℓ and 5.0 g/ℓ, and said reagent being capable of dividing the leukocytes into at least two fractions.
Claim 8
Dependent Claim 73 words
The reagent according to Claim 1 containing at least two of said quaternary ammonium salts, with the total concentration of said quaternary ammonium salt of salts ranging between 2.2 g/ℓ and 5.0 g/ℓ, said reagent also containing at least one of oxidants selected from f, with the total concentration of said oxidant or oxidants ranging between 0.5 g/ℓ and 10.0 g/ℓ, and said reagent being capable of dividing the leukocytes into three fractions.
Claim 9
Dependent Claim 73 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total concentration of said quaternary ammonium salt or salts ranging between 1.0 g/ℓ and 10.0 g/ℓ, said reagent also containing at least one of said pyridinium salts, with the total concentration of said pyridinium salt or salts ranging between 1.0 g/ℓ and 5.0 g/ℓ, and said reagent being capable of dividing the leukocytes into three fractions.
Claim 10
Dependent Claim 73 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total concentration of the quaternary ammonium salt or salts ranging between 3.0 g/ℓ and 12.0 g/ℓ, said reagent also containing at least one of said nonionic surfactants, with the total concentration of said nonionic surfactant or surfactants ranging between 1.0 g/ℓ and 12.0 g/ℓ, and said reagent being capable of dividing the leukocytes into three fractions.
Claim 11
Dependent Claim 73 words
The reagent according to Claim 1 containing at least one of said quaternary ammonium salts, with the total concentration of the quaternary ammonium salt or salts ranging between 1.0 g/ℓ and 10.0 g/ℓ, said reagent also containing at least one of said amphoteric surfactants, with the total concentration of said amphoteric surfactant or surfactants ranging between 0.1 g/ℓ and 10.0 g/ℓ, and said reagent being capable of dividing the leukocytes into three fractions.

References Cited (Backward Citations)

US4185964A Cited
WO1984002777A1 Cited
WO1984003771A1 Cited
WO1984004969A1 Cited
EP0177137A2 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag